LeonardJosephHorwitzMD

PubMed

• 213 citations
  High-dose chemoradiotherapy and autologous bone marrow transplantation for resistant multiple myeloma
  Bail Barlogie, Raymond Alexanian, Karel A. Dicke, Gunar K. Zagars, G. Spitzer
  Blood. 1987-09-01
• 6 citations
  Hb grove city [β38(C4)Thr→Ser, ACC>AGC; HBB: C.116C>G]: A new low oxygen affinity β chain variant
  Rachel M. Taliercio, Rendell W. Ashton, Leonard J. Horwitz, Kenneth C. Swanson, Patricia Wendt
  Hemoglobin. 2013-07-01
• 181 citations
  High-Dose Cyclophosphamide, Carmustine, and Etoposide and Autologous Bone Marrow Transplantation for Relapsed Hodgkin's Disease
  Sundar Jagannath, Karel A. Dicke, James O. Armitage, Fernando Cabanillas, Leonard J. Horwitz
  Annals of Internal Medicine. 1986-02-01

Journal Articles

• High-dose cyclophosphamide, BCNU, and VP-16 with autologous blood stem cell support for refractory multiple myeloma  
  Ventura GJ, Barlogie B, Hester JP, Yau JC, LeMaistre CF, Wallertein RO, Spinolo J, Dicke KA, Horwitz LJ, and Alexanian R, Bone Marrow Transplantation, 1/1/1990
• Treatment of estrogen receptor negative or hormonally refractory breast cancer with double high dose chemotherapy intensification and bone marrow support  
  Dunphy FR, Spitzer G, Buzdar AU, Hortobagyi GN, Horwitz LJ, Yau JC, et al, J Clin Oncol, 1/1/1990
• Treatment of estrogen receptor negative or hormonally refractory breast cancer with double high dose chemotherapy intensification and bone marrow support.  
  Dunphy FR, Spitzer G, Buzdar AU, Hortobagyi GN, Horwitz LJ, Yau JC, et al., J Clin Oncol, 1/1/1990
• High-dose cyclophosphamide, BCNU, and VP-16 with autologous blood stem cell support for refractory multiple myeloma.  
  Ventura GJ, Barlogie B, Hester JP, Yau JC, LeMaistre CF, Wallertein RO, Spinolo J, Dicke KA, Horwitz LJ, and Alexanian R, Bone Marrow Transplantation, 1/1/1990
• Prognostic factors for response and survival after high dose cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation for relapsed hodgk...  
  Jagannath S, Armitage JO, Dicke KA, Tucker SL, Velasquez WS, Smith K, Vaughan WP, Kessinger A, Horwitz LJ, Hagemeister FB, McLaughlin P, Cabanillas F, Spitzer G, J Clin Oncol, 1/1/1989
• Piperazinedione plus total body irradiation: an alternative preparative regimen for allogeneic bone marrow transplantation in post-accelerated phases of chronic myelog...  
  Horwitz LJ, Kantarjian HM, Jagannath S, Keating MJ, McCredie KB, Spitzer G, Vellekoop L, Zander AR, Dicke KA, Bone Marrow Transplantation, 1/1/1989
• Piperazinedione plus total body irradiation: an alternative preparative regimen for allogeneic bone marrow transplantation in post-accelerated phases of chronic myelog...  
  Horwitz LJ, Kantarjian HM, Jagannath S, Keating MJ, McCredie KB, Spitzer G, Vellekoop L, Zander AR, Dicke KA, Bone Marrow Transplantation, 1/1/1989
• Prognostic factors for response and survival after high dose cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation for relapsed hodgk...  
  Jagannath S, Armitage JO, Dicke KA, Tucker SL, Velasquez WS, Smith K, Vaughan WP, Kessinger A, Horwitz LJ, Hagemeister FB, McLaughlin P, Cabanillas F, Spitzer G, J Clin Oncol, 1/1/1989
• Evaluation of drugs for elimination of leukemic cells from the bone marrow of patients with acute leukemia  
  Auber ML, Horwitz LJ, Blaauw A, Khorana S, Tucker S, Woods T, Warmuth M, Dicke KA, McCredie KB, and Spitzer G, Blood, 1/1/1988
• Evaluation of drugs for elimination of leukemic cells from the bone marrow of patients with acute leukemia.  
  Auber ML, Horwitz LJ, Blaauw A, Khorana S, Tucker S, Woods T, Warmuth M, Dicke KA, McCredie KB, and Spitzer G, Blood, 1/1/1988
• The role of autologous bone marrow transplantation in acute leukemia.  
  Dicke KA, Jagannath S, Walter RS, Horwitz LJ, McCredie KB, Spitzer G, Ann NY Acad Sci, 1/1/1987
• High-dose chemoradiotherapy and autologous bone marrow transplantation for resistant multiple myeloma  
  Barlogie B, Alexanian R, Dicke KA, Zagars G, Spitzer G, Jagannath S, and Horwitz LJ, Blood, 1/1/1987
• High-dose cyclophosphamide, BCNU, and VP-16 (CBV) as a conditioning regimen for allogenic bone marrow transplantation for patients with acute leukemia  
  Zander AR, Culbert S, Jagannath S, Spitzer G, Keating M Larry N, Cockerill K, Horwitz LJ, Vellekoop L, Swan F, McCredie KB, and Dicke KA, Cancer, 1/1/1987
• The role of autologous bone marrow transplantation in acute leukemia  
  Dicke KA, Jagannath S, Walter RS, Horwitz LJ, McCredie KB, Spitzer G, Ann NY Acad Sci, 1/1/1987
• High-dose chemoradiotherapy and autologous bone marrow transplantation for resistant multiple myeloma.  
  Barlogie B, Alexanian R, Dicke KA, Zagars G, Spitzer G, Jagannath S, and Horwitz LJ, Blood, 1/1/1987
• High-dose cyclophosphamide, BCNU, and VP-16 (CBV) as a conditioning regimen for allogenic bone marrow transplantation for patients with acute leukemia.  
  Zander AR, Culbert S, Jagannath S, Spitzer G, Keating M Larry N, Cockerill K, Horwitz LJ, Vellekoop L, Swan F, McCredie KB, and Dicke KA, Cancer, 1/1/1987
• High-dose cyclophosphamide, BCNU, and etoposide followed by autologous bone marrow rescue as treatment for adult leukemia in relapse.  
  Vellecoop L, Jagannath S, Spitzer G, Zander AR, Horwitz LJ, Keating M, McCredie KB, and Dicke KA, Am J Clinical Oncol (CCT), 1/1/1986
• High-dose cyclophosphamide, carmustine, and etoposide and autologous bone marrow transplantation of relapsed Hodgkin’s disease  
  Jagannath S, Dicke KA, Armitage JO, Cabanillas F, Horwitz LJ, Vellekoop L, Zander AR, Spitzer G, Ann Internal Med, 1/1/1986
• High dose melphalan and total body irradiation with bone marrow rescue transplantation for refractory malignancies  
  Spitzer G, Jagannath S, Dicke KA, Armitage J, Zander AR, Vellekoop L, Horwitz LJ, Cabanillas F, Zagars GK, and Velaquez WS, European J Cl Oncol, 1/1/1986
• High-dose cyclophosphamide, BCNU, and etoposide followed by autologous bone marrow rescue as treatment for adult leukemia in relapse  
  Vellecoop L, Jagannath S, Spitzer G, Zander AR, Horwitz LJ, Keating M, McCredie KB, and Dicke KA, Am J Clinical Oncol (CCT), 1/1/1986
• High dose melphalan and total body irradiation with bone marrow rescue transplantation for refractory malignancies.  
  Spitzer G, Jagannath S, Dicke KA, Armitage J, Zander AR, Vellekoop L, Horwitz LJ, Cabanillas F, Zagars GK, and Velaquez WS, European J Cl Oncol, 1/1/1986
• High-dose cyclophosphamide, carmustine, and etoposide and autologous bone marrow transplantation of relapsed Hodgkin's disease.  
  Jagannath S, Dicke KA, Armitage JO, Cabanillas F, Horwitz LJ, Vellekoop L, Zander AR, Spitzer G, Ann Internal Med, 1/1/1986
• Multiple myeloma in three siblings.  
  Horwitz LJ, Levy RN, Rosner F, Arch Internal Med, 1/1/1985
• Multiple myeloma in three siblings  
  Horwitz LJ, Levy RN, Rosner F, Arch Internal Med, 1/1/1985
• Critical care for the aplastic anemia patient  
  Ewer MS, Clarke VM, Horwitz LJ, Cancer Bulletin, 1/1/1985
• Join now to see all

Books/Book Chapters

• First Consult (on line) 
  Chapter: Bleeding Disorders. 
  Horwitz LJ2012
• First Consult (Online) 
  Chapter: Bleeding Disorders 
  Horwitz LJ2012
• Perioperative Management of Patients with Rheumatic Disease 
  Chapter: Perioperative Management of the Neutropenic Rhemumatologic Patient 
  Page 155 - 163Horwitz LJEditors: Mandell BF.Springer Science + Business Media, LLC2012
• Perioperative Management of Patients with Rheumatic Disease 
  Chapter: Perioperative Management of the Neutropenic Rhemumatologic Patient. 
  Horwitz LJEditors: Mandell BF.Springer Science + Business Media, LLCEdition 155,2012
• First Consult (Online) 
  Chapter: von Willebrand’s Disease 
  Horwitz LJ2010
• First Consult (on line) 
  Chapter: von Willebrand's Disease. 
  Horwitz LJ2010
• First Consult (on line) 
  Chapter: Hemophilia. 
  Horwitz LJ2010
• First Consult (Online) 
  Chapter: Hemophilia 
  Horwitz LJ2010
• Autologous Bone Marrow Transplantation: Proceedings of the Fifth International Symposium 
  Chapter: High dose chemotherapy and autologous bone marrow transplantation for adult acute lymphoblastic leukemia in first remission 
  Page 151 - 160Spinolo JA, Dicke KA, Horwitz LJ, Kantarjian H, Jagannath S, Spitzer GEditors: Dicke KA, Armitage JO, Evinger-Hodges MJ.The University of Nebraska Medical Center1991
• Autologous Bone Marrow Transplantation: Proceedings of the Fifth International Symposium 
  Chapter: Tandem high dose chemotherapy for metastatic breast cancer. 
  Page 323 - 332Spitzer G, Huan S, Dunphy FR, Buzdar AU, Hortobagyi GN, Horwitz LJ, Yau JC, Spinolo JA, Jagannath S, Holmes F, Wallerstein RO, Dicke KAEditors: Dicke KA, Armitage JO, Evinger-Hodges MJ.The University of Nebraska Medical Center1991
• Autologous Bone Marrow Transplantation: Proceedings of the Fifth International Symposium 
  Chapter: High dose chemotherapy and autologous bone marrow transplantation for adult acute lymphoblastic leukemia in first remission. 
  Page 151 - 160Spinolo JA, Dicke KA, Horwitz LJ, Kantarjian H, Jagannath S, Spitzer GEditors: Dicke KA, Armitage JO, Evinger-Hodges MJ.The University of Nebraska Medical Center1991
• Autologous Bone Marrow Transplantation: Proceedings of the Fifth International Symposium 
  Chapter: High dose chemotherapy and unpurged autologous bone marrow transplantation for acute leukemia in second or subsequent remission. 
  Page 65 - 75Spinolo JA, Dicke KA, Horwitz LJ, Jagannath S, Estey E, Kantarjian H, Zander AR, Spitzer GEditors: Dicke KA, Armitage JO, Evinger-Hodges MJ.The University of Nebraska Medical Center1991
• Autologous Bone Marrow Transplantation: Proceedings of the Fifth International Symposium 
  Chapter: Tandem high dose chemotherapy for metastatic breast cancer 
  Page 323 - 332Spitzer G, Huan S, Dunphy FR, Buzdar AU, Hortobagyi GN, Horwitz LJ, Yau JC, Spinolo JA, Jagannath S, Holmes F, Wallerstein RO, Dicke KAEditors: Dicke KA, Armitage JO, Evinger-Hodges MJ.The University of Nebraska Medical Center1991
• Autologous Bone Marrow Transplantation: Proceedings of the Fifth International Symposium 
  Chapter: High dose chemotherapy and unpurged autologous bone marrow transplantation for acute leukemia in second or subsequent remission 
  Page 65 - 75Spinolo JA, Dicke KA, Horwitz LJ, Jagannath S, Estey E, Kantarjian H, Zander AR, Spitzer GEditors: Dicke KA, Armitage JO, Evinger-Hodges MJ.The University of Nebraska Medical Center1991
• Autologous Bone Marrow Transplantation: Proceedings of the Fourth International Symposium 
  Chapter: Does high dose intensification with autologous bone marrow rescue contribute to long term disease free survival in acute myelogenous leukemia in first remission? 
  Page 3 - 12Dicke KA, Spinolo JA, Horwitz LJ, Jagannath S, Spitzer GEditors: Dicke KA, Spitzer G, Jagannath S, Evinger-Hodges MJ.The University of Texas M.D. Anderson Cancer Center1989
• Autologous Bone Marrow Transplantation: Proceedings of the Fourth International Symposium 
  Chapter: Chemopurge with 4-Hydroperoxycyclophosphamide and vincristine in second or subsequent remission of acute leukemia: Is inversion rate an appropriate parameter? 
  Page 67 - 72Horwitz LJ, Dicke KA, Spinolo JA, Jagannath S, Spitzer GEditors: Dicke KA, Spitzer G, Jagannath S, Evinger-Hodges MJ.The University of Texas M.D. Anderson Cancer Center1989
• Autologous Bone Marrow Transplantation: Proceedings of the Fourth International Symposium 
  Chapter: Timing of high dose CBV and autologous bone marrow transplantat in the management of relapsed or refractory Hodgkin's disease. 
  Page 275 - 283Jagannath S, Armitage JO, Dicke KA, Tucker SL, Velasquez WS, Smith K, Vaughn WP, Kessinger A, Horwitz LJ, Hagemeister GB, Cabanillas F, Spitzer GEditors: Dicke KA, Spitzer G, Jagannath S, Evinger-Hodges MJ.The University of Texas M.D. Anderson Cancer Center1989
• Autologous Bone Marrow Transplantation: Proceedings of the Fourth International Symposium 
  Chapter: High dose intensification for stage IV hormonally refractory breast cancer. 
  Page 399 - 403Spitzer G, Dunphy FR, Ellis JK, Buzdar AU, Hortobagyi GN, Holmes FA, Jabboury KW, Horwitz LJ, Jagannath S, Dicke KAEditors: Dicke KA, Spitzer G, Jagannath S, Evinger-Hodges MJ.The University of Texas M.D. Anderson Cancer Center1989
• Autologous Bone Marrow Transplantation: Proceedings of the Fourth International Symposium 
  Chapter: Intravenous and/or oral immunoglobulin for autologous marrow transplantation: An interim report. 
  Page 753 - 758Horwitz LJ, Pilat SR, Chang NW, Fogel B, Dunphy FR, Jagannath S, Spitzer G, Dicke KAEditors: Dicke KA, Spitzer G, Jagannath S, Evinger-Hodges MJ.The University of Texas M.D. Anderson Cancer Center1989
• Autologous Bone Marrow Transplantation: Proceedings of the Fourth International Symposium 
  Chapter: Timing of high dose CBV and autologous bone marrow transplantat in the management of relapsed or refractory Hodgkin’s disease 
  Page 275 - 283Jagannath S, Armitage JO, Dicke KA, Tucker SL, Velasquez WS, Smith K, Vaughn WP, Kessinger A, Horwitz LJ, Hagemeister GB, Cabanillas F, Spitzer GEditors: Dicke KA, Spitzer G, Jagannath S, Evinger-Hodges MJ.The University of Texas M.D. Anderson Cancer Center1989
• Autologous Bone Marrow Transplantation: Proceedings of the Fourth International Symposium 
  Chapter: High dose intensification for stage IV hormonally refractory breast cancer 
  Page 399 - 403Spitzer G, Dunphy FR, Ellis JK, Buzdar AU, Hortobagyi GN, Holmes FA, Jabboury KW, Horwitz LJ, Jagannath S, Dicke KAEditors: Dicke KA, Spitzer G, Jagannath S, Evinger-Hodges MJ.The University of Texas M.D. Anderson Cancer Center1989
• Autologous Bone Marrow Transplantation: Proceedings of the Fourth International Symposium 
  Chapter: Intravenous and/or oral immunoglobulin for autologous marrow transplantation: An interim report 
  Page 753 - 758Horwitz LJ, Pilat SR, Chang NW, Fogel B, Dunphy FR, Jagannath S, Spitzer G, Dicke KAEditors: Dicke KA, Spitzer G, Jagannath S, Evinger-Hodges MJ.The University of Texas M.D. Anderson Cancer Center1989
• Autologous Bone Marrow Transplantation: Proceedings of the First International Symposium 
  Chapter: Pharmacological treatment of bone marrow grafts 
  Page 383 - 388Zander AR, Show H, Yau J, Kulkarni SS, Horwitz LJ, Jagannath S, Spitzer G, Vellekoop L, Dicke KAEditors: Dicke KA, Spitzer G, Zander AR.The University of Texas M.D. Anderson Hospital and Tumor Institute, Houston1988
• Autologous Bone Marrow Transplantation: Proceedings of the First International Symposium 
  Chapter: Pharmacological treatment of bone marrow grafts. 
  Page 383 - 388Zander AR, Show H, Yau J, Kulkarni SS, Horwitz LJ, Jagannath S, Spitzer G, Vellekoop L, Dicke KAEditors: Dicke KA, Spitzer G, Zander AR.The University of Texas M.D. Anderson Hospital and Tumor Institute at Houston1988
• Experimental Hematology Today. Recent Advances and Future Directions in Bone Marrow Transplantation 
  Chapter: Perspectives in treatment of adult leukemia with high dose cytoreductive therapy and autologous bone marrow treated ex vivo 
  Page 58 - 73Horwitz LJ, Dicke KA, Jagannath S, and Spitzer GEditors: Baurn SJ, Santos GW, and Takaku.1987
• Join now to see all

Abstracts/Posters

• A prospective, randomized, chemoprevention trial of celecoxib for high risk monoclonal gammopathy of undetermined significance and asymptomatic multiple myeloma
  Horwitz LJ, Faiman B, Elson PJ, Baz RC, Hussein M, Lust JA, Mehta P, Reu FJ, Habecker B, Reed J, Karam MA, Hsi ED, Sobecks RM, Dean RS, Kaushal V and Kalaycio M, American Society of Hematology, 1/1/2012
• Anemia associated with increased IL-6 and IL-8 levels predicts for worse progression free survival in T-cell and NK-cell large granular lymphocyte Leukemia, but is imp...
  Portell CA, Visconte V, Clemente M, Afable M, Tabarroki A, Traina F, Liu Y, Hamilton B, Jarez A, Bupathi M, Advani AS, Horwitz LJ, Lichtin A, Sekeres MA, Meciejewski J..., American Society of Hematology, 1/1/2012
• Anemia associated with increased IL-6 and IL-8 levels predicts for worse progression free survival in T-cell and NK-cell large granular lymphocyte Leukemia, but is imp...
  Portell CA, Visconte V, Clemente M, Afable M, Tabarroki A, Traina F, Liu Y, Hamilton B, Jarez A, Bupathi M, Advani AS, Horwitz LJ, Lichtin A, Sekeres MA, Meciejewski J..., American Society of Hematology, 1/1/2012
• A prospective, randomized, chemoprevention trial of celecoxib for high risk monoclonal gammopathy of undetermined significance and asymptomatic multiple myeloma.
  Horwitz LJ, Faiman B, Elson PJ, Baz RC, Hussein M, Lust JA, Mehta P, Reu FJ, Habecker B, Reed J, Karam MA, Hsi ED, Sobecks RM, Dean RS, Kaushal V and Kalaycio M, American Society of Hematology, 1/1/2012
• High dose chemotherapy intensification with bone marrow support for hormone receptor negative or hormonal refractory relapsing breast cancer
  Dunphy FR, Spitzer G, Suzbar A, Hortobagyi G, Horwitz LJ, Yau J, Spinolo J, Jagannath S, and Dicke KA, Biennial International Breast Cancer Research Conference, Tel Aviv University, Tel Aviv, 3/5/1989
• High dose chemotherapy intensification with bone marrow support for hormone receptor negative or hormonal refractory relapsing breast cancer (Meeting Abstract).
  Dunphy FR, Spitzer G, Suzbar A, Hortobagyi G, Horwitz LJ, Yau J, Spinolo J, Jagannath S, and Dicke KA, Biennial International Breast Cancer Research Conference, Tel Aviv University, Tel Aviv, 3/5/1989
• Second or subsequent remission intensification in acute leukemia with high dose chemotherapy and autologous bone marrow treated with drugs ex vivo
  Horwitz LJ, Spitzer G, Auber MK, Jagannath S, Keating KJ, McCredie KB, and Dicke KA, Journal of Cellular Biochemistry, 1/1/1988
• Long term follow up on high dose chemotherapy (HDCT) and autologous bone marrow transplantation (ABMT) and remission intensification for acute myelogenous leukemia (AML)
  Dicke KA, Spinolo JA, McCredie KB, Horwitz LJ, Jagannath S, Spitzer G, Proceedings of ASCO, 1/1/1988
• Occurrence of severe acute graft vs. host disease (AGVHD) with T-cells depleted allogeneic bone marrow transplantation (BMT) in adults with advanced refractory hematol...
  Spinolo JA, Jagannath S, Zagars GK, Kantarjian H, Horwitz LJ, Dunphy F, Spitzer G, McCredie KB, and Dickie KA, Proceedings of ASCO, 1/1/1988
• Autologous bone marrow transplant hastens hematopoietic recovery post high dose chemotherapy.
  Dunphy F, Auber M, Spitzer G, Dicke K, Jagannath S, Horwitz LJ, Spinolo J, Buzdar A, Holmes F, Jabboury K, Hotobagyi G, Proceedings of AACR, 1/1/1988
• Occurrence of severe acute graft vs. host disease (AGVHD) with T-cells depleted allogeneic bone marrow transplantation (BMT) in adults with advanced refractory hematol...
  Spinolo JA, Jagannath S, Zagars GK, Kantarjian H, Horwitz LJ, Dunphy F, Spitzer G, McCredie KB, and Dickie KA, Proceedings of ASCO, 1/1/1988
• Long term follow up on high dose chemotherapy (HDCT) and autologous bone marrow transplantation (ABMT) and remission intensification for acute myelogenous leukemia (AML).
  Dicke KA, Spinolo JA, McCredie KB, Horwitz LJ, Jagannath S, Spitzer G, Proceedings of ASCO, 1/1/1988
• Second or subsequent remission intensification in acute leukemia with high dose chemotherapy and autologous bone marrow treated with drugs ex vivo.
  Horwitz LJ, Spitzer G, Auber MK, Jagannath S, Keating KJ, McCredie KB, and Dicke KA, Journal of Cellular Biochemistry, 1/1/1988
• Autologous bone marrow transplant hastens hematopoietic recovery post high dose chemotherapy
  Dunphy F, Auber M, Spitzer G, Dicke K, Jagannath S, Horwitz LJ, Spinolo J, Buzdar A, Holmes F, Jabboury K, Hotobagyi G, Proceedings of AACR, 1/1/1988
• High-dose combination chemotherapy with cyclophosphamide, carmustine, etoposide and autologous bone marrow transplantation in 60 patients with relapsed Hodgkin’s disea...
  Spinolo JA, Jagannath S, Dicke KA, Smith KB, Cabanillas F, Hagemeister FB, Horwitz LJ, McLaughlin P, Swan F, and Spitzer G, International Symposium on Hodgkin’s Lymphoma, Cologne Germany, 10/2/1987
• High-dose combination chemotherapy with cyclophosphamide, carmustine, etoposide and autologous bone marrow transplantation in 60 patients with relapsed Hodgkin's disea...
  Spinolo JA, Jagannath S, Dicke KA, Smith KB, Cabanillas F, Hagemeister FB, Horwitz LJ, McLaughlin P, Swan F, and Spitzer G, International Symposium on Hodgkin's Lymphoma, Cologne, Germany, 10/2/1987
• Remission intensification with high dose cyclophosphamide BCNU and VP-16 (CBV) and autologous bone marrow transplantation (ABMT) in acute myelogenous leukemia (AML)
  Dicke KA, Horwitz LJ, Spinolo J, Dixon D, Spitzer G, Jagannath S, American Society of Hematology, 1/1/1987
• Autologous bone marrow transplantation (ABMT) for relapsed Hodgkin’s disease
  Jagannath S, Armitage JO, Dicke KA, Hagemeister FB, Tucker SL, Horwitz LJ, Velasquez WS, Vaughn WP, Kessinger A, Cabanillas F, and Spitzer G, Third International Conference on Malignant Lymphoma, Lugano, Italy, 1/1/1987
• 4-Hydroperpxycyclophosphamide (4-HC) and vincristine as ex vivo bone marrow treatment for acute leukemia in second remission
  Auber M, Horwitz LJ, Spitzer G, Khorana S, Jagannath S, McCredie K, and Dicke KA, First International Workshop on Bone Marrow Purging, Gainesville, FL, 1/1/1987
• Autologous Bone Marrow Transplantation (ABMT) hastens hematopoietic recovery after severe myelosuppressive but non-marrow ablative chemotherapy
  Auber M, Dunphy F, Spitzer G, Dicke KA, Jagannath S, Horwitz LJ, Spinolo J, Buzdar A, Holmes F, Jabboury K, Hortobagyi G, American Society of Hematology, 1/1/1987
• High dose cyclophosphamied/VP-16/platinum (CVP) intensifications for patients with metastatic breast cancer
  Spitzer G, Budzar A, Auber M, Horwitz LJ, jagannath S, Holmes F, Jabboury K, Hortobagyi G, and Dicke KA, Tenth Annual Breast Cancer Symposium, San Antonio, TX, 1/1/1987
• High dose cyclophosphamied/VP-16/platinum (CVP) intensifications for patients with metastatic breast cancer.
  Spitzer G, Budzar A, Auber M, Horwitz LJ, jagannath S, Holmes F, Jabboury K, Hortobagyi G, and Dicke KA, Tenth Annual Breast Cancer Symposium, San Antonio, TX, 1/1/1987
• Autologous Bone Marrow Transplantation (ABMT) hastens hematopoietic recovery after severe myelosuppressive but non-marrow ablative chemotherapy.
  Auber M, Dunphy F, Spitzer G, Dicke KA, Jagannath S, Horwitz LJ, Spinolo J, Buzdar A, Holmes F, Jabboury K, Hortobagyi G, American Society of Hematology, 1/1/1987
• 4-Hydroperpxycyclophosphamide (4-HC) and vincristine as ex vivo bone marrow treatment for acute leukemia in second remission.
  Auber M, Horwitz LJ, Spitzer G, Khorana S, Jagannath S, McCredie K, and Dicke KA, First International Workshop on Bone Marrow Purging, Gainesville, FL, 1/1/1987
• Autologous bone marrow transplantation (ABMT) for relapsed Hodgkin's disease.
  Jagannath S, Armitage JO, Dicke KA, Hagemeister FB, Tucker SL, Horwitz LJ, Velasquez WS, Vaughn WP, Kessinger A, Cabanillas F, and Spitzer G, Third International Conference on Malignant Lymphoma, Lugano, Italy, 1/1/1987
• Join now to see all

Lectures

• Bone Marrow Transplantation: Information for Medical and Nursing Directors of Managed Care and Insurance Programs. 
  Jewish Hospital, Cincinnati, OH - 6/25/1992
• Bone Marrow Transplantation: Information for Medical and Nursing Directors of Managed Care and Insurance Programs 
  Cincinnati, OH - 6/25/1992
• Bone Marrow Transplantation: Opportunities and Challenges for the Nineties. 
  Westin Hotel, Cincinnati, OH - 10/10/1991
• Bone Marrow Transplantation: Opportunities and Challenges for the Nineties 
  Cincinnati, OH - 10/10/1991
• Bone Marrow Transplantation. 
  Dayton, OH - 5/1/1991
• Bone Marrow Transplantation 
  Dayton, OH - 5/1/1991
• Role of Intravenous Immunoglobulins in Autologous Bone Marrow Transplantation. 
  Glendale, CA - 2/1/1989
• Role of Intravenous Immunoglobulins in Autologous Bone Marrow Transplantation 
  Glendale, CA - 2/1/1989
• Join now to see all